Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Link of Recording
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has shared the audio recording link of its earnings and analyst conference call held on August 11, 2025 at 12:00 PM, which discussed the un-audited financial results for Q1 FY26. The filing is submitted under SEBI's Listing Obligations and Disclosure Requirements. The company has stated that the transcript of the call will be shared with the stock exchanges and uploaded on its website shortly. This is a routine procedural disclosure and does not contain any new financial details.
This filing has no direct impact on shareholders or stock price. Investors who want to understand management's commentary on Q1 FY26 performance should listen to the recording or wait for the transcript, which may contain forward-looking guidance or outlook.